Anita Deshpande
Hematology & Oncology · Asheville, NCNPI 1538137526
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $957 and has fallen 96.0% since, to $38 in 2021. That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.
Across 64 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$178
- AstraZeneca$96
- Pfizer$88
- Johnson & Johnson$71
- Daiichi Sankyo Inc.$60
- Genentech USA, Inc.$59
- plus $492 from 22 others
What the payments were for
- Food & beverage$1,044100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 11 | $178 |
| AstraZeneca(2 entities) | 5 | $96 |
| Pfizer | 6 | $88 |
| Johnson & Johnson(2 entities) | 5 | $71 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Genentech USA, Inc. | 3 | $59 |
| Bayer | 2 | $38 |
| Taiho Oncology, Inc. | 2 | $35 |
| EMD Serono, Inc. | 2 | $34 |
| Tersera Therapeutics LLC | 2 | $30 |
| Merck | 2 | $29 |
| Kyowa Kirin, Inc. | 2 | $29 |
| Sanofi | 2 | $27 |
| Novartis | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Tesaro, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| AbbVie | 1 | $20 |
| Novocure Inc. | 1 | $19 |
| Array Biopharma Inc | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Exelixis Inc. | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Clovis Oncology, Inc. | 1 | $14 |
| Incyte Corporation | 1 | $13 |
How this compares
$1,044 in reported general payments places this provider in the 40th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Asheville
- Sean WarschAsheville$37K
- Amit MehtaCary$4.3M
- Michael MorseDurham$2.6M
- Shelbi AtrashCharlotte$994K
- Phillip FebboDurham$749K
- Angela AlistarWinston Salem$509K
- Ravi PaluriWinston Salem$314K
- Matthew McKinneyDurham$277K
- Jared WeissChapel Hill$217K
- Joshua ZeidnerChapel Hill$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.